Follow
Helene Karcher, PhD
Title
Cited by
Cited by
Year
A three-dimensional viscoelastic model for cell deformation with experimental verification
H Karcher, J Lammerding, H Huang, RT Lee, RD Kamm, ...
Biophysical journal 85 (5), 3336-3349, 2003
2802003
The “efficacy-effectiveness gap”: historical background and current conceptualization
C Nordon, H Karcher, RHH Groenwold, MZ Ankarfeldt, F Pichler, ...
Value in Health 19 (1), 75-81, 2016
1462016
Force-induced focal adhesion translocation: effects of force amplitude and frequency
PJ Mack, MR Kaazempur-Mofrad, H Karcher, RT Lee, RD Kamm
American journal of physiology-Cell Physiology 287 (4), C954-C962, 2004
992004
Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: a network meta-analysis of progression-free survival and overall survival in second …
B Amzal, S Fu, J Meng, J Lister, H Karcher
PloS one 12 (9), e0184423, 2017
572017
Role of simulation in understanding biological systems
MR Kaazempur-Mofrad, M Bathe, H Karcher, HF Younis, HC Seong, ...
Computers & structures 81 (8-11), 715-726, 2003
502003
Exploring the molecular basis for mechanosensation, signal transduction, and cytoskeletal remodeling
MRK Mofrad, NA Abdul-Rahim, H Karcher, PJ Mack, B Yap, RD Kamm
Acta biomaterialia 1 (3), 281-293, 2005
442005
Proportion of women and reporting of outcomes by sex in clinical trials for Alzheimer disease: a systematic review and meta-analysis
J Martinkova, FC Quevenco, H Karcher, A Ferrari, EC Sandset, C Szoeke, ...
JAMA Network Open 4 (9), e2124124-e2124124, 2021
372021
Nivolumab versus cabozantinib: comparing overall survival in metastatic renal cell carcinoma
W Wiecek, H Karcher
PLoS One 11 (6), e0155389, 2016
362016
From target selection to the minimum acceptable biological effect level for human study: use of mechanism-based PK/PD modeling to design safe and efficacious biologics
J Yu, H Karcher, AL Feire, PJ Lowe
The AAPS journal 13, 169-178, 2011
232011
Efficacy and safety of brolucizumab in age‐related macular degeneration: A systematic review of real‐world studies
CR Baumal, TL Sørensen, H Karcher, RL Freitas, A Becher, S Balez, ...
Acta Ophthalmologica 101 (2), 123-139, 2023
192023
A coarse-grained model for force-induced protein deformation and kinetics
H Karcher, SE Lee, MR Kaazempur-Mofrad, RD Kamm
Biophysical journal 90 (8), 2686-2697, 2006
192006
Comparative efficacy of brolucizumab in the treatment of neovascular age-related macular degeneration: a systematic literature review and network meta-analysis
RP Finger, N Dennis, R Freitas, A Quenechdu, A Clemens, H Karcher, ...
Advances in Therapy 39 (8), 3425-3448, 2022
122022
Anti–vascular endothelial growth factor treatment discontinuation and interval in neovascular age-related macular degeneration in the United States
SJ Bakri, H Karcher, S Andersen, EH Souied
American Journal of Ophthalmology 242, 189-196, 2022
112022
Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison
C Porta, C Szczylik, R Casciano, S Fu, B Amzal, J Lister, H Karcher, ...
Critical Reviews in Oncology/Hematology 139, 143-148, 2019
112019
Retinal vasculitis or vascular occlusion after brolucizumab for neovascular age-related macular degeneration : a systematic review of real-world evidence
CC Wykoff, H Matsumoto, MR Barakat, H Karcher, A Lozama, A Mayhook, ...
Retina (Philadelphia, Pa.), 2023
102023
4 Continuum elastic or viscoelastic models for the cell
MRK Mofrad, H Karcher, RD Kamm
This page intentionally left blank, 71, 2006
102006
Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: a case study using the SOHO database
C Nordon, T Bovagnet, M Belger, J Jimenez, R Olivares, ...
Schizophrenia Research 193, 146-153, 2018
92018
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration
JM Coney, R Zubricky, SB Sinha, N Sonbolian, L Zhou, TP Hull, SA Lewis, ...
International Journal of Retina and Vitreous 9 (1), 8, 2023
72023
The treatment patterns with brolucizumab in Germany (realize) study: a retrospective cohort study based on longitudinal prescription data
RG Liegl, H Karcher, S Chetty-Mhlanga, F Igwe, R Freitas
Ophthalmology and Therapy 12 (1), 195-208, 2023
62023
Ethical and Social implications of using predictive modeling for Alzheimer’s disease prevention: a systematic literature review
Z Angehrn, J Sostar, C Nordon, A Turner, D Gove, H Karcher, A Keenan, ...
Journal of Alzheimer's Disease 76 (3), 923-940, 2020
52020
The system can't perform the operation now. Try again later.
Articles 1–20